Rallybio Corporation

NasdaqGS:RLYB 주식 보고서

시가총액: US$44.8m

Rallybio 관리

관리 기준 확인 2/4

Rallybio CEO는 Steve Uden, Jan2018 에 임명되었습니다 의 임기는 6.83 년입니다. 총 연간 보상은 $ 1.78M, 29.8% 로 구성됩니다. 29.8% 급여 및 70.2% 보너스(회사 주식 및 옵션 포함). 는 $ 776.66K 가치에 해당하는 회사 주식의 1.73% 직접 소유합니다. 776.66K. 경영진과 이사회의 평균 재임 기간은 각각 5.8 년과 4.1 년입니다.

주요 정보

Steve Uden

최고 경영자

US$1.8m

총 보상

CEO 급여 비율29.8%
CEO 임기6.8yrs
CEO 소유권1.7%
경영진 평균 재임 기간5.8yrs
이사회 평균 재임 기간4.1yrs

최근 관리 업데이트

Recent updates

We Think Rallybio (NASDAQ:RLYB) Needs To Drive Business Growth Carefully

Aug 28
We Think Rallybio (NASDAQ:RLYB) Needs To Drive Business Growth Carefully

Is Rallybio (NASDAQ:RLYB) In A Good Position To Deliver On Growth Plans?

Jan 04
Is Rallybio (NASDAQ:RLYB) In A Good Position To Deliver On Growth Plans?

Is Rallybio (NASDAQ:RLYB) In A Good Position To Invest In Growth?

Sep 19
Is Rallybio (NASDAQ:RLYB) In A Good Position To Invest In Growth?

Here's Why We're Not Too Worried About Rallybio's (NASDAQ:RLYB) Cash Burn Situation

May 15
Here's Why We're Not Too Worried About Rallybio's (NASDAQ:RLYB) Cash Burn Situation

We Think Rallybio (NASDAQ:RLYB) Can Afford To Drive Business Growth

Jan 30
We Think Rallybio (NASDAQ:RLYB) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About Rallybio's (NASDAQ:RLYB) Cash Burn Situation

Oct 31
Here's Why We're Not Too Worried About Rallybio's (NASDAQ:RLYB) Cash Burn Situation

Here's Why We're Not Too Worried About Rallybio's (NASDAQ:RLYB) Cash Burn Situation

Jul 07
Here's Why We're Not Too Worried About Rallybio's (NASDAQ:RLYB) Cash Burn Situation

Rallybio (NASDAQ:RLYB) Is In A Good Position To Deliver On Growth Plans

Mar 16
Rallybio (NASDAQ:RLYB) Is In A Good Position To Deliver On Growth Plans

CEO 보상 분석

Steve Uden 의 보수는 Rallybio 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

-US$67m

Jun 30 2024n/an/a

-US$74m

Mar 31 2024n/an/a

-US$76m

Dec 31 2023US$2mUS$530k

-US$75m

Sep 30 2023n/an/a

-US$71m

Jun 30 2023n/an/a

-US$71m

Mar 31 2023n/an/a

-US$69m

Dec 31 2022US$1mUS$491k

-US$67m

Sep 30 2022n/an/a

-US$63m

Jun 30 2022n/an/a

-US$55m

Mar 31 2022n/an/a

-US$48m

Dec 31 2021US$3mUS$441k

-US$47m

Sep 30 2021n/an/a

-US$45m

Jun 30 2021n/an/a

-US$42m

Mar 31 2021n/an/a

-US$36m

Dec 31 2020US$838kUS$380k

-US$26m

보상 대 시장: Steve 의 총 보상 ($USD 1.78M )은 US 시장( $USD 647.72K ).

보상과 수익: 회사가 수익성이 없는 동안 Steve 의 보상이 증가했습니다.


CEO

Steve Uden (66 yo)

6.8yrs

테뉴어

US$1,778,284

보상

Dr. Stephen Uden, also known as Steve, MD, is Chief Executive Officer and Director of Rallybio, LLC since August 01, 2023 and serves as its President. Dr. Uden is a Co-Founder of Rallybio, LLC in 2018 and...


리더십 팀

이름위치테뉴어보상소유권
Martin MacKay
Co-Founder & Executive Chairman6.8yrsUS$1.78m1.73%
$ 776.7k
Stephen Uden
Co-Founder6.8yrsUS$1.78m1.73%
$ 776.7k
Jonathan Lieber
CFO & Treasurer1.8yrsUS$1.91m0.012%
$ 5.4k
Steven Ryder
Chief Medical Officer5.8yrsUS$1.27m0.46%
$ 207.8k

5.8yrs

평균 재임 기간

67yo

평균 연령

경험이 풍부한 관리: RLYB 의 관리팀은 노련하고 경험 (평균 재직 기간 5.8 년)입니다.


이사회 구성원

이름위치테뉴어보상소유권
Martin MacKay
Co-Founder & Executive Chairman6.8yrsUS$1.78m1.73%
$ 776.7k
Stephen Uden
Co-Founder1.3yrsUS$1.78m1.73%
$ 776.7k
Ronald Hunt
Independent Director6.8yrsUS$115.45k0%
$ 0
Robert Hopfner
Independent Director4.7yrsUS$115.45k0%
$ 0
Christine Nash
Independent Director2.6yrsUS$108.95k0%
$ 0
Helen Boudreau
Independent Director4.2yrsUS$118.95k0.058%
$ 25.8k
Lucian Iancovici
Independent Director4.5yrs데이터 없음데이터 없음
Paula Soteropoulos
Independent Director4.1yrsUS$113.95k0.058%
$ 25.8k
Wendy Chung
Independent Director2.3yrsUS$95.00k0%
$ 0
Hui Liu
Independent Director2.6yrsUS$111.45k0%
$ 0

4.1yrs

평균 재임 기간

56.5yo

평균 연령

경험이 풍부한 이사회: RLYB 의 이사회경험(평균 재직 기간 4.1 년)으로 간주됩니다.